FDA Emphasizes Pathogen ID In Complicated Intra-Abdominal Infection Guidance
Executive Summary
The agency checked another box on the list of guidances anticipated by developers of antibiotic drugs with the Oct. 1 release of a draft guidance on treatments for complicated intra-abdominal infections.